Leading global ophthalmic CRO Ora announces appointment of pharmaceutical industry veteran Bill Sharbaugh as Chairman of Board of Directors.

Axsome Therapeutics AXSM has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ...

The combined company plans to launch ZELSUVMI™ for the treatment of molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, the combined company closed on a $50. ...

Sage Therapeutics is laying off most of its employees after announcing its planned acquisition earlier this month.

Summit Therapeutics stock rises after report of potential $15B AstraZeneca deal Author Louis Juricic Stock Markets Published 07/03/2025, 10:28 AM ...

AbbVie said on Monday it would acquire privately held cell therapy developer Capstan Therapeutics in a deal worth up to $2.1 billion, expanding its product pipeline with experimental treatments ...

Cambridge biotech firm Sage Therapeutics is laying off most of its employees after announcing its planned acquisition earlier this month. Sage will cut 338 jobs effective Aug. 22, according to ...

AbbVie acquires Capstan Therapeutics for $2.1 billion: The deal adds a first-in-class in vivo chimeric antigen receptor (CAR) T-cell therapy candidate, CPTX2309, to AbbVie’s immunology pipeline.

Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity By George Budwell – Jul 4, 2025 at 4:30AM ...

Merck KGaA expands rare tumor portfolio: The $3.4 billion acquisition of SpringWorks Therapeutics adds two FDA-approved therapies: Ogsiveo for desmoid tumors and Gomekli for neurofibromatosis type 1 ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June 30, 2025 that were previo ...

-- AstraZeneca is in talks with Summit Therapeutics for a deal in which it could pay as much as $15 billion over time to license a lung-cancer drug, Bloomberg reported Thursday, citing people ...